MeSH term
Frequency | Condition_Probility | Animals | 27 | 0.0 |
Base Sequence | 2 | 0.0 |
Binding Sites | 2 | 0.0 |
Comparative Study | 7 | 0.0 |
Mice | 19 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 27 | 0.0 |
Species Specificity | 4 | 0.0 |
Transcription Factors | 2 | 2.0 |
Amino Acid Sequence | 3 | 0.0 |
Cattle | 3 | 0.0 |
Humans | 56 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Biosynthesis | 2 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 19 | 0.0 |
beta-Galactosidase/metabolism | 3 | 1.0 |
Cells, Cultured | 9 | 0.0 |
*Drug Resistance, Multiple | 2 | 1.0 |
Female | 18 | 0.0 |
Male | 15 | 0.0 |
Middle Aged | 9 | 0.0 |
Fluorescent Dyes | 2 | 0.0 |
Rats | 6 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Mice, Inbred BALB C | 3 | 0.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
Time Factors | 3 | 0.0 |
alpha-N-Acetylgalactosaminidase | 3 | 33.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Adult | 7 | 0.0 |
Aged | 5 | 0.0 |
Lymphocytes/immunology | 4 | 1.0 |
Macrophages/immunology | 4 | 1.0 |
Substrate Specificity | 3 | 0.0 |
Glycosylation | 2 | 0.0 |
Immunity, Cellular | 4 | 0.0 |
Lymphocytes/*immunology | 2 | 0.0 |
Macrophages/*immunology | 6 | 2.0 |
Monocytes/*immunology | 5 | 1.0 |
Macrophage Activation | 8 | 4.0 |
*Macrophage Activation | 8 | 14.0 |
Mutation | 2 | 0.0 |
Cytotoxicity, Immunologic | 13 | 1.0 |
Hybridomas/immunology | 2 | 1.0 |
Lymphocyte Activation | 12 | 0.0 |
T-Lymphocytes/*immunology | 3 | 0.0 |
In Vitro | 4 | 0.0 |
Interleukin-2/*pharmacology | 2 | 0.0 |
Receptors, IgG | 2 | 1.0 |
Receptors, Interleukin-2/immunology | 2 | 3.0 |
Cell Line | 12 | 0.0 |
Interferon Type II/pharmacology | 3 | 0.0 |
Molecular Weight | 2 | 0.0 |
T-Lymphocytes/*metabolism | 2 | 0.0 |
Interferon Type II/physiology | 2 | 2.0 |
Neoplasms/*immunology | 2 | 1.0 |
English Abstract | 2 | 0.0 |
Interferon Type II/immunology | 3 | 3.0 |
Phagocytosis | 2 | 0.0 |
T-Lymphocytes/immunology | 4 | 0.0 |
Lymphokines/analysis | 2 | 2.0 |
Macrophage-Activating Factors | 28 | 84.0 |
Antigens, Surface/analysis | 3 | 0.0 |
Hydrogen Peroxide/metabolism | 2 | 1.0 |
Temperature | 2 | 0.0 |
Cell Transformation, Viral | 2 | 0.0 |
Deltaretrovirus | 2 | 25.0 |
Monocytes/immunology | 2 | 0.0 |
Lymphokines/biosynthesis | 3 | 2.0 |
*Cytotoxicity, Immunologic | 7 | 1.0 |
Macrophage Activation/*drug effects | 3 | 8.0 |
Guinea Pigs | 4 | 0.0 |
Lymphokines/biosynthesis/physiology | 2 | 50.0 |
Rabbits | 2 | 0.0 |
Rats, Inbred Lew | 2 | 0.0 |
Spleen/cytology | 2 | 1.0 |
Cytotoxicity Tests, Immunologic | 3 | 0.0 |
Lymphokines/*biosynthesis | 3 | 1.0 |
Hamsters | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Lymphokines/*pharmacology | 3 | 1.0 |
Neutralization Tests | 2 | 0.0 |
Chromatography, Gel | 2 | 0.0 |
Isoelectric Focusing | 2 | 0.0 |
Lymphokines/*isolation & purification | 2 | 22.0 |
Chronic Disease | 2 | 0.0 |
Hepatitis/*immunology | 2 | 28.0 |
Liver/*immunology | 2 | 5.0 |
Drug Hypersensitivity/*immunology | 2 | 28.0 |